Literature DB >> 27296295

Breast cancer: The 21-gene recurrence score - biology remains at the forefront.

Shannon L Puhalla1, Nancy E Davidson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27296295     DOI: 10.1038/nrclinonc.2016.98

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

1.  Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Authors:  Soonmyung Paik; Gong Tang; Steven Shak; Chungyeul Kim; Joffre Baker; Wanseop Kim; Maureen Cronin; Frederick L Baehner; Drew Watson; John Bryant; Joseph P Costantino; Charles E Geyer; D Lawrence Wickerham; Norman Wolmark
Journal:  J Clin Oncol       Date:  2006-05-23       Impact factor: 44.544

2.  ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

Authors:  F Cardoso; A Costa; L Norton; E Senkus; M Aapro; F André; C H Barrios; J Bergh; L Biganzoli; K L Blackwell; M J Cardoso; T Cufer; N El Saghir; L Fallowfield; D Fenech; P Francis; K Gelmon; S H Giordano; J Gligorov; A Goldhirsch; N Harbeck; N Houssami; C Hudis; B Kaufman; I Krop; S Kyriakides; U N Lin; M Mayer; S D Merjaver; E B Nordström; O Pagani; A Partridge; F Penault-Llorca; M J Piccart; H Rugo; G Sledge; C Thomssen; L Van't Veer; D Vorobiof; C Vrieling; N West; B Xu; E Winer
Journal:  Breast       Date:  2014-09-20       Impact factor: 4.380

3.  A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.

Authors:  Martin Filipits; Margaretha Rudas; Raimund Jakesz; Peter Dubsky; Florian Fitzal; Christian F Singer; Otto Dietze; Richard Greil; Andrea Jelen; Paul Sevelda; Christa Freibauer; Volkmar Müller; Fritz Jänicke; Marcus Schmidt; Heinz Kölbl; Achim Rody; Manfred Kaufmann; Werner Schroth; Hiltrud Brauch; Matthias Schwab; Peter Fritz; Karsten E Weber; Inke S Feder; Guido Hennig; Ralf Kronenwett; Mathias Gehrmann; Michael Gnant
Journal:  Clin Cancer Res       Date:  2011-08-01       Impact factor: 12.531

Review 4.  Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Lyndsay N Harris; Nofisat Ismaila; Lisa M McShane; Fabrice Andre; Deborah E Collyar; Ana M Gonzalez-Angulo; Elizabeth H Hammond; Nicole M Kuderer; Minetta C Liu; Robert G Mennel; Catherine Van Poznak; Robert C Bast; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2016-02-08       Impact factor: 44.544

5.  Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.

Authors:  Joseph A Sparano; Robert J Gray; Della F Makower; Kathleen I Pritchard; Kathy S Albain; Daniel F Hayes; Charles E Geyer; Elizabeth C Dees; Edith A Perez; John A Olson; JoAnne Zujewski; Tracy Lively; Sunil S Badve; Thomas J Saphner; Lynne I Wagner; Timothy J Whelan; Matthew J Ellis; Soonmyung Paik; William C Wood; Peter Ravdin; Maccon M Keane; Henry L Gomez Moreno; Pavan S Reddy; Timothy F Goggins; Ingrid A Mayer; Adam M Brufsky; Deborah L Toppmeyer; Virginia G Kaklamani; James N Atkins; Jeffrey L Berenberg; George W Sledge
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

6.  Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.

Authors:  M Gnant; M Filipits; R Greil; H Stoeger; M Rudas; Z Bago-Horvath; B Mlineritsch; W Kwasny; M Knauer; C Singer; R Jakesz; P Dubsky; F Fitzal; R Bartsch; G Steger; M Balic; S Ressler; J W Cowens; J Storhoff; S Ferree; C Schaper; S Liu; C Fesl; T O Nielsen
Journal:  Ann Oncol       Date:  2013-12-16       Impact factor: 32.976

7.  Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.

Authors:  Tari A King; Jaclyn P Lyman; Mithat Gonen; Amy Voci; Marina De Brot; Camilla Boafo; Amy Pratt Sing; E Shelley Hwang; Michael D Alvarado; Minetta C Liu; Judy C Boughey; Kandace P McGuire; Catherine H Van Poznak; Lisa K Jacobs; Ingrid M Meszoely; Helen Krontiras; Gildy V Babiera; Larry Norton; Monica Morrow; Clifford A Hudis
Journal:  J Clin Oncol       Date:  2016-03-21       Impact factor: 44.544

8.  21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile.

Authors:  Jagar Jasem; Arya Amini; Rachel Rabinovitch; Virginia F Borges; Anthony Elias; Christine M Fisher; Peter Kabos
Journal:  J Clin Oncol       Date:  2016-03-21       Impact factor: 44.544

9.  Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis.

Authors:  Molly E Klein; David J Dabbs; Yongli Shuai; Adam M Brufsky; Rachel Jankowitz; Shannon L Puhalla; Rohit Bhargava
Journal:  Mod Pathol       Date:  2013-03-15       Impact factor: 7.842

  9 in total
  1 in total

1.  An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.

Authors:  Dan Xue; Pu Cheng; Mengjiao Han; Xiyong Liu; Lijun Xue; Chenyi Ye; Ke Wang; Jian Huang
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.